Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Essential Healthcare News.
Press releases published on June 5, 2025
FDA Approved Anticancer Peptide Drug Conjugate Market Clinical Trials Insight
GlobeNewswire
·
June 5, 2025
Delhi, June 05, 2025 (GLOBE NEWSWIRE) -- Global Peptide Drug Conjugate Market, Drug Sales, Price, Dosage and Clinical Trials Insight 2030 Report Highlights: Global Peptide Drug Conjugate Market Opportunity: > USD 1400 Million Global Peptide Drug Conjugate …
Axillary Hyperhidrosis Treatment Market to Surpass USD 3.42 Billion by 2035 at 6.0% CAGR
EIN Presswire
·
June 5, 2025
Growing Awareness Drives Axillary Hyperhidrosis Treatment Market to USD 3.42 Billion by 2035 NEW YORK, DE, UNITED STATES, June 5, 2025 /EINPresswire.com/ -- Global sales of axillary hyperhidrosis treatment reached approximately USD 1.91 billion in 2025, …
Roquette Appoints Thierry Fournier as Chief Executive Officer
GlobeNewswire
·
June 5, 2025
Roquette Appoints Thierry Fournier as Chief Executive Officer Lille, France, June 5, 2025 - Roquette, a global leader in plant-based ingredients and pharmaceutical excipients for health, nutrition and bio industrial markets, announces the appointment of …
Roquette nomme Thierry Fournier au poste de Directeur Général
GlobeNewswire
·
June 5, 2025
Roquette nomme Thierry Fournier au poste de Directeur Général Lille, France, 5 juin 2025 - Roquette, un leader mondial des ingrédients d’origine végétale et des excipients pharmaceutiques destinés aux secteurs de la santé, de la nutrition et de la bio- …
The Foundation for Sarcoidosis Research and American Thoracic Society Announce Dr. Mark Mallozzi as the New FSR/ATS Partner Grant Awardee
GlobeNewswire
·
June 5, 2025
CHICAGO, June 05, 2025 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) and the American Thoracic Society (ATS) are pleased to announce that Mark Mallozzi, MD, MPH has been selected to receive the 2025 ATS/FSR Partner Grant, awarded to …
Dilated Cardiomyopathy Market Witnesses Robust Growth During the Study Period (2020–2034) Amid Advancements in Cardiovascular Therapies | DelveInsight
GlobeNewswire
·
June 5, 2025
New York, USA, June 05, 2025 (GLOBE NEWSWIRE) -- Dilated Cardiomyopathy Market Witnesses Robust Growth During the Study Period (2020–2034) Amid Advancements in Cardiovascular Therapies | DelveInsight The dilated cardiomyopathy market is experiencing …
Global Antidote Market to Cross the USD 4 Billion Mark by 2032 | DelveInsight
GlobeNewswire
·
June 5, 2025
New York, USA, June 05, 2025 (GLOBE NEWSWIRE) -- Global Antidote Market to Cross the USD 4 Billion Mark by 2032 | DelveInsight The antidote market is witnessing substantial growth, largely propelled by the growing incidence of poisoning, drug overdoses, …
Treace Files Patent Infringement Suit Against Zimmer Biomet to Protect Lapiplasty® Bunion Technology
GlobeNewswire
·
June 5, 2025
PONTE VEDRA, Fla., June 05, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities …
Scilex Holding Company Announces Publication on GLOPERBA® Dosing Adjustments in Peer-Review Journal
GlobeNewswire
·
June 5, 2025
PALO ALTO, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the …
Atherosclerosis Market to Reach USD 62.2 Billion by 2035, Growing at 2.7% CAGR
EIN Presswire
·
June 5, 2025
Atherosclerosis Market Forecasted to Expand from USD 47.6 Billion in 2025 to USD 62.2 Billion by 2035 NEW YORK, DE, UNITED STATES, June 5, 2025 /EINPresswire.com/ -- The global atherosclerosis market is projected to grow from USD 47.6 billion in 2025 to …
Valneva Reports Positive Six-Month Antibody Persistence and Safety Phase 2 Results in Children for its Single-Shot Chikungunya Vaccine IXCHIQ®
GlobeNewswire
·
June 5, 2025
IXCHIQ® was well tolerated by children aged one to eleven years regardless of the dose or previous chikungunya infection (CHIKV) Antibody levels remained high after six months in both dose groups, although more robust with the full dose Six-month data …
Valneva annonce des résultats positifs de Phase 2 à six mois sur la persistance des anticorps et l’innocuité de son vaccin à dose unique contre le chikungunya IXCHIQ® chez les enfants
GlobeNewswire
·
June 5, 2025
IXCHIQ® a été bien toléré par les enfants âgés d’un à onze ans indépendamment de la dose de vaccin reçue (dose complète ou demi-dose) ou d’une précédente infection au virus du chikungunya Les niveaux d’anticorps demeurent élevés après six mois dans les …
Merus N.V. gibt Preis für öffentliches Angebot von Stammaktien bekannt
GlobeNewswire
·
June 5, 2025
UTRECHT, Niederlande, und CAMBRIDGE, Massachusetts, June 05, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) („Merus“, das „Unternehmen“, „wir“ und „unser“), ein Onkologieunternehmen, das innovative, multispezifische Antikörper in voller Länge und …
Merus N.V. annonce la fixation du prix de l’offre publique d’actions ordinaires
GlobeNewswire
·
June 5, 2025
UTRECHT, Pays-Bas et CAMBRIDGE, État du Massachusetts, 05 juin 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), ci-après « Merus », la « Société », « nous » ou « notre/nos », une société spécialisée dans l’oncologie développant des anticorps …
Fertility Pregnancy Rapid Test Kits Market Set to Expand from USD 1.60 Billion in 2025 to USD 2.49 Billion by 2035
EIN Presswire
·
June 5, 2025
Fertility …
Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset
GlobeNewswire
·
June 5, 2025
SARASOTA, FL, June 05, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced that its Board of Directors …
Outset Medical to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire
·
June 5, 2025
SAN JOSE, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that management will …
Telehealth Market & Telemedicine Market to Hit US$180.86 Billion by 2030 with 11.5% CAGR | MarketsandMarkets™
GlobeNewswire
·
June 5, 2025
Delray Beach, FL, June 05, 2025 (GLOBE NEWSWIRE) -- The Telehealth Market …
Artelo’s Fatty Acid Binding Protein 5 Inhibitor, ART26.12, Compares Favorably to Naproxen in an Osteoarthritis Pain Study
GlobeNewswire
·
June 5, 2025
SOLANA BEACH, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, …
Bitcoin Life Insurance Company Meanwhile Achieves Historic Bitcoin Milestone with First-Ever Audited BTC-Denominated Financial Statements
GlobeNewswire
·
June 5, 2025
HAMILTON, Bermuda, June 05, 2025 (GLOBE NEWSWIRE) -- Meanwhile Insurance Bitcoin (Bermuda) Limited (“Meanwhile” or the “Company”), the world’s first life insurance company fully denominated in Bitcoin (“BTC”), today announced the completion and public …